Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)
Spain · Delayed Price · Currency is EUR 59.05
+0.45 (0.77%)
Aug 7, 2026, 1:03 PM CET
BME:ROVI Market Cap
BME:ROVI has a market cap or net worth of €3 billion as of August 7, 2026. Its market cap has increased by 12.68% in one year.
Market Cap
3.00B
Enterprise Value
2.99B
Revenue
773.05M
Ranking
n/a
PE Ratio
16.18
Stock Price
€59.05
ChartMarket Cap Chart
Since December 18, 2007, BME:ROVI's market cap has increased from 356.09K to 3.00B, an increase of 841,535.45%. That is a compound annual growth rate of 62.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 3.00B | -7.73% |
| Dec 31, 2025 | 3.25B | 0.87% |
| Dec 31, 2024 | 3.22B | 0.22% |
| Dec 29, 2023 | 3.21B | 66.93% |
| Dec 30, 2022 | 1.92B | -53.49% |
| Dec 30, 2021 | 4.14B | 97.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.01B |
| Almirall | 2.39B |
| Faes Farma | 1.40B |
| Pharma Mar | 1.36B |
| Clínica Baviera | 978.02M |
| Oryzon Genomics | 239.00M |
| Prim, S.A. | 226.28M |
| Laboratorio Reig Jofre | 223.88M |